Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Dorsi

Neurological Surgery Thousand Oaks, CA Medical Doctor

NPI 1942355854 CMS profile 178712

100 Moody Ct Ste 200, Thousand Oaks, CA 91360

Open in the dashboard

General payments

$616,762

1,701 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$9,800 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Michael Dorsi of Thousand Oaks, CA is reported in the CMS Open Payments database as having received $616,762 across 1,701 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $9,800 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $63,122 194
2024 General $98,979 262
2023 General $103,821 191
2022 General $116,966 301
2021 General $66,940 210
2020 General $79,277 232
2019 General $87,658 311

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Dorsi
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Michael Dorsi were reported at $63,122. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Michael Dorsi Neurological Surgery median Middle half National median
2019 $87,658 $582 $138–$3,006 $163
2020 $79,277 $294 $76–$2,174 $114
2021 $66,940 $387 $105–$2,432 $132
2022 $116,966 $542 $139–$2,989 $149
2023 $103,821 $534 $145–$2,697 $160
2024 $98,979 $574 $155–$3,046 $164
2025 $63,122 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $202,960 386 payments
  2. The Institute of Musculoskeletal Science and Education $95,471 21 payments
  3. Abbott Laboratories $79,652 231 payments
  4. NuVasive, Inc. $68,048 200 payments
  5. Globus Medical, Inc. $39,277 226 payments
  6. Ferring Pharmaceuticals Inc. $33,052 24 payments
  7. Painteq LLC $21,488 25 payments
  8. Life Spine, Inc. $13,770 13 payments
  9. Saluda Medical Americas, Inc. $13,152 28 payments
  10. BIOTRONIK NRO, Inc. $9,347 37 payments
  11. Other $40,545 510 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $204,144 90 payments
  2. Royalty or License $94,971 20 payments
  3. Compensation for serving as faculty or as a speaker for a medical education program $72,961 31 payments
  4. Travel and Lodging $64,288 183 payments
  5. Food and Beverage $61,553 1,331 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $60,000 14 payments
  7. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $44,174 29 payments
  8. Education $14,671 3 payments
Products named General payments · program years 2019–2025
  1. Senza Spinal Cord Stimulation System $79,584 143 payments
  2. PROCLAIM $73,096 132 payments
  3. Omnia $52,306 111 payments
  4. Spira-C $35,914 9 payments
  5. Vyrsa V1 $35,360 26 payments
  6. Senza $34,846 18 payments
  7. Spira $34,240 8 payments
  8. Spira-L $27,850 4 payments
  9. XLIF $24,818 61 payments
  10. PAINTEQ $21,488 25 payments
  11. Other $150,421 1,257 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 52 billing codes

Paid by Medicare

$123,850

Medicare's payments for the services billed

Medicare patients

360

Average age 73

Services billed

603

165 women, 195 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 38%
Diabetes 31%
Depression 30%
Chronic kidney disease 20%
Osteoporosis 20%
Atrial fibrillation 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,701 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record